Phaos Technology Holdings (Cayman) (POAS) Shares Outstanding (Diluted Average) (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) reported Shares Outstanding (Diluted Average) of $25.7 million for Q4 2025, up 34.01% quarter-over-quarter from $19.2 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Shares Outstanding (Diluted Average) (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) has reported Shares Outstanding (Diluted Average) for 2 years, with the latest figure at $25.7 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) changed N/A year-over-year to $25.7 million; the trailing twelve-month figure through Oct 2025 stood at $25.7 million (changed N/A YoY), and the FY2025 full-year result was $19.2 million, up 9.94% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $25.7 million, up from $19.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $25.7 million in Q4 2025, with the low at $17.5 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Phaos Technology Holdings (Cayman) | 682,234.12 | 627,245.12 | - | 25.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 25.73 Mn |
| Apr 30, 2025 | 19.20 Mn |
| Apr 30, 2024 | 17.48 Mn |